基本信息
浏览量:575
职业迁徙
个人简介
Since 2003, he has been a faculty member, initially as Instructor and then as Assistant Professor of Medicine, at Dana-Farber Cancer Institute and Harvard Medical School. His research work has focused on understanding the cell-autonomous and microenvironment-driven mechanisms of tumor cell resistance to pharmacological and immune based therapies; and on developing novel therapies which neutralize the ability of tumor cells to develop resistance to currently available anti-cancer treatments. For instance, Dr. Mitsiades' studies documented that nonmalignant "accessory" cells of the tumor microenvironment, e.g. bone marrow stromal cells, can cause resistance to several different types of pharmacological therapies as well as immune effector cells, such as NK cells and cytotoxic T-cells. These studies led to further validation of this concept in many other types of cancers. Dr. Mitsiades has published more than 200 articles in peer-reviewed scientific journals (including Cell, Nature Medicine, Cancer Cell, etc.), and in 2014 Dr. Mitsiades was included in the list of the "World’s Most Influential Scientific Minds" compiled by Thomson-Reuters. Many of his myeloma-oriented studies translated to improved therapies for patients with this disease, including combination regimens (e.g. combinations of proteasome inhibitors with thalidomide derivatives, alkylators, anthracyclines, histone deacetylase inhibitors or Bcl-2 family member inhibitors) which have been FDA-approved, represent a standard-of-care for myeloma or have demonstrated very promising clinical data. Building on this experience, Dr. Mitsiades' research team has applied in recent years the concepts and models from their myeloma research towards the bench-to-bedside development of novel therapies for both advanced hematologic malignancies and metastatic solid tumors.
研究兴趣
论文共 623 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Amin Sobh, Elena Encinas,Alisha Patel, Greeshma Surapaneni, Charlotte Kaestner, Janai Poullard, Monica Clerio,Karthik Vasan, Tzipporah Freeman, Dongwen Lv,Daphne Dupere-Richer,Alberto Riva,
Cancer Researchno. 6_Supplement (2024): 7058-7058
Cancer Researchno. 6 (2024): 938-938
Cancer researchno. 6 (2024): 938-938
Weicheng Li,Enrique M Garcia-Rivera,Dylan C Mitchell,Joel M Chick,Micah Maetani, John M Knapp,Geoffrey M Matthews,Ryosuke Shirasaki,Ricardo de Matos Simoes, Vasanthi Viswanathan,John L Pulice, Matthew G Rees,
bioRxiv : the preprint server for biology (2024)
Hematology/Oncology Clinics of North Americano. 2 (2024): 321-336
Cancer researchno. 6 (2024): 939-939
Yu-Tzu Tai, Laurence P Catley,Constantine S Mitsiades,Renate Burger,Klaus Podar, Reshma Shringpaure,Teru Hideshima,Dharminder Chauhan, Makoto Hamasaki,Kenji Ishitsuka,Paul Richardson,Steven P Treon,
Cancer researchno. 6 (2024): 936-936
Constantine S. Mitsiades,Enrique M. Ocio,Atanasio Pandiella,Patricia Maiso,Consuelo Gajate,Mercedes Garayoa, David Vilanova,Juan Carlos Montero,Nicholas Mitsiades, Ciaran J. McMullan,Nikhil C. Munshi,Teru Hideshima,
crossref(2023)
Blood (2023): 6842
Constantine S. Mitsiades,Enrique M. Ocio,Atanasio Pandiella,Patricia Maiso,Consuelo Gajate,Mercedes Garayoa, David Vilanova,Juan Carlos Montero,Nicholas Mitsiades, Ciaran J. McMullan,Nikhil C. Munshi,Teru Hideshima,
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn